Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nitrous oxide is a colorless, non-flammable gas with a slightly sweet odor and taste. It is widely used in medicine as an inhaled anesthetic and analgesic agent for procedures in surgery and dentistry. Its mechanism of action involves antagonism of the N-methyl-D-aspartate (NMDA) receptor in the central nervous system, leading to sedation and pain relief. Nitrous oxide has rapid onset and offset due to its low solubility in blood. It is also known for causing euphoria when inhaled—hence the nickname "laughing gas." In addition to medical uses, it has applications as a propellant in food processing and as an oxidizer in industry. Chronic or high-dose exposure can cause neurological toxicity (notably via vitamin B12 inhibition), anemia, or hypoxia if not administered with oxygen[1][4][9][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nitrous oxide.